Vitamin A, Beta-Carotene and Vitamin E: study protocols
7 study groups took Vitamin A together with Beta-Carotene and Vitamin E. These are the doses the studies gave. They are not a recommendation.
Dose per serving from research: Vitamin A
5 study groups in 4 studies say how much Vitamin A participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 2,500 IU to 5,000 IU and 10,000 IU to 25,000 IU, 40% of 5 study groups each.
| Daily dose | Study groups |
|---|---|
| 2,500 IU to 5,000 IU | 2 |
| 5,000 IU to 10,000 IU | 0 |
| 10,000 IU to 25,000 IU | 2 |
| 25,000 IU to 50,000 IU | 1 |
Dose per serving from research: Beta-Carotene
7 study groups in 6 studies say how much Beta-Carotene participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 25 mg to 50 mg, 57% of 7 study groups.
| Daily dose | Study groups |
|---|---|
| 5 mg or less | 1 |
| 5 mg to 10 mg | 0 |
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 4 |
Dose per serving from research: Vitamin E
7 study groups in 6 studies say how much Vitamin E participants took a day.
These are the doses the studies gave. They are not a recommendation.
Most common: 10 mg to 25 mg and 25 mg to 50 mg, 29% of 7 study groups each.
| Daily dose | Study groups |
|---|---|
| 10 mg to 25 mg | 2 |
| 25 mg to 50 mg | 2 |
| 50 mg to 100 mg | 1 |
| 100 mg to 250 mg | 1 |
| 250 mg to 500 mg | 1 |
Commonly used together
6 of 7 study groups took Vitamin A, Beta-Carotene and Vitamin E with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Vitamin C | 4 |
7 study groups
| Study | |||||
|---|---|---|---|---|---|
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 14,286 IU | 40 mg | 11.4 mg | 87 weeks | — |
| Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension 2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women | 5,000 IU | 30 mg | 30 mg | — | — |
| Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer 1993 · riboflavin plus retinol, beta-carotene, and vitamin E · Men aged 50–69 with oral leukoplakia and/or chronic esophagitis | 14,286 IU | 40 mg | 11.4 mg | 87 weeks | — |
| Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function 2003 · group B [high dose of supplement] · Patients with cystic fibrosis; age and sex not specified | 500 mcg | 25 mg | 200 mg | 8 weeks | — |
| Effect of vitamin supplementation on breast milk concentrations of retinol, carotenoids and tocopherols in HIV-infected Tanzanian women 2009 · multivitamins including vitamin A and β-carotene · HIV-infected pregnant women enrolled at 12–27 weeks of gestation in Dar es Salaam, Tanzania; women breastfeeding postpartum | 5,000 IU | 30 mg | 30 mg | — | — |
| Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) 1996 · intervention group · Patients with suspected acute myocardial infarction; age and sex not stated | 50,000 IU | 25 mg | 400 mg | 4 weeks | 63 |
| [Effect of multiple micronutrients supplementation on anti-oxidative activity and oxidized DNA damage of lymphocytes in children] 2005 · supplement group · Chinese children aged 9–11 years, described as healthy and living in a rural area | 600 mcg | 1 mg | 100 mg | 8 weeks | 41 |